11.07  -0.93 (-7.75%)		07-12 14:29
Open: 11.1 High: 11.1 Volume: 16,992		Pre. Close: 12 Low: 11.07 Market Cap: 146(M)

Short term
Mid term
Targets	6-month :	14.27	1-year :	15.17
Resists	First :	12.22	Second :	12.98
Pivot price	11.08
Supports	First :	10.98	Second :	9.14
MAs	MA(5) :	11.22	MA(20) :	11.06
	MA(100) :	10.9	MA(250) :	10.75
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	22.5	D(3) :	27.3
RSI	RSI(14): 49.9
52-week	High :	12.98	Low :	10.47

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ VCXB ] has closed above bottom band by 48.2%. Bollinger Bands are 859.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	11.11 - 11.18	11.18 - 11.23
Low:	10.92 - 10.99	10.99 - 11.06
Close:	10.97 - 11.08	11.08 - 11.18

10X Capital Venture Acquisition Corp. III does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to identify business opportunities in the field of consumer internet, e-commerce, software, healthcare, transportation/mobility, financial services, artificial intelligence, automation, data science, and Software-as-a-Service. The company was incorporated in 2021 and is based in New York, New York.

Wed, 10 Jul 2024
10X Capital delays shareholder meeting to July 12 - Investing.com

Fri, 21 Jun 2024
10X Capital ends merger with American Gene Technologies - Investing.com

Thu, 07 Dec 2023
Watkins Advises 10X Capital Venture Acquisition Corp. II in Business Combination With African Agriculture, Inc. - Latham & Watkins LLP -

Tue, 31 Oct 2023
Addimmune Prepares to Go Public, Initiate Phase Ib HIV Trial - BioBuzz

Mon, 18 Sep 2023
Why the First Clinical Cure for HIV Will Likely be Developed in Maryland - BioBuzz

Thu, 10 Aug 2023
SPAC 10X Capital III to merge with HIV therapy developer Addimmune (VCXB) - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Financial Services
Industry: Shell Companies
Shares Out	13 (M)
Shares Float	2 (M)
Held by Insiders	0 (%)
Held by Institutions	111.9 (%)
Shares Short	1 (K)
Shares Short P.Month	1 (K)

EPS	-0.08
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-1.25
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-3.1 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	1 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-138.38
PEG Ratio	0
Price to Book value	-8.93
Price to Sales	0
Price to Cash Flow	281.34

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.